high-grade B-cell lymphoma (HGBL)

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

high-grade B-cell lymphoma (HGBL)

Feb 13, 2025, 06:52 | Drugs

FDA Approved Brentuximab Vedotin Combo for Relapsed/Refractory LBCL

On February 11, 2025, the FDA approved the use of brentuximab vedotin (Adcetris, Seagen Inc.,…

All: 1 Posts: 1 - 100

'

Douglas Hanahan was Honored with the 2025 Pezcoller Foundation-AACR International Award for Extraordinary Cancer Research

'

Bente Mikkelsen Appointed as Director of Global Engagement Strategies at St. Jude Children's Research Hospital

'

Audrey Evans - mother of neuroblastoma, a force for good in the world

'

New Paper Alert: Management of Immune Checkpoint Inhibitor-Associated Toxicities in Older Adults with Cancer

'

Kimryn Rathmell was Awarded 2025 ACS Medal of Honor

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023